Journal of Public Health Policy

, Volume 32, Issue 3, pp 391–398

Conflicts of interest and the future of medicine: The United States, France and Japan

  • Alain Braillon
Book Review
  • 10 Downloads

References

  1. Crowe, F.L. et al (2011) Fruit and vegetable intake and mortality from ischaemic heart disease: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) – Heart study. European Heart Journal, advance online publication 18 January, doi:10.1093/eurheartj/ehq465.Google Scholar
  2. Gardiner, H. (2010) Doctor faces suits over cardiac stents. The New York Times 5 December: A15, http://www.nytimes.com/2010/12/06/health/06stent.html, accessed 16 March 2011.
  3. Al-Khatib, S.M. et al (2011) Non-evidence-based ICD implantations in the United States. Journal of the American Medical Association 305 (1): 43–49.CrossRefGoogle Scholar
  4. ASTRAL Investigators et al (2009) Revascularization versus medical therapy for renal-artery stenosis. The New England Journal of Medicine 361 (20): 1953–1962.Google Scholar
  5. Braillon, A. (2009) Medical devices and the approval processes: United States vs France. Archives of Internal Medicine 170 (22): 2040–2041.Google Scholar
  6. Jang, T.L. et al (2010) Physician visits prior to treatment for clinically localized prostate cancer. Archives of Internal Medicine 170 (5): 440–450.CrossRefGoogle Scholar
  7. National Institute for Health and Clinical Excellence. (2011) Transitional cell carcinoma of the urothelial tract – Vinflunine: Final appraisal determination. 7 March, http://guidance.nice.org.uk/TA/Wave23/13/FAD, accessed 16 March 2011.
  8. Editorial. (2009) L’Agence européenne du médicament censure les données de pharmacovigilance. Rev Prescrire 29 (309): 536, http://www.prescrire.org/editoriaux/EDI33693.pdf, accessed 16 March 2011.
  9. Almashat, S., Preston, C., Waterman, T. and Wolfe, S. (2010) Rapidly increasing criminal and civil monetary penalties against the pharmaceutical industry: 1991 to 2010. 16 December, http://www.citizen.org/hrg1924, accessed 16 March 2011.
  10. Gornall, J. (2009) Industry attack on academics. British Medical Journal: 338–b736.Google Scholar
  11. Goodman, B. (n.d.) Corporation for non-promotion-based medicine. About us, http://www.nofreelunch.org/aboutus.htm, accessed 16 March 2011.
  12. Jelinek, G.A. and Brown, A.F. (2011) A stand against drug company advertising. Emergency Medicine Australasia 23 (1): 4–6.CrossRefGoogle Scholar
  13. Braillon, A. (2010) Homoeopathic remedies and drug-regulatory authorities. Lancet 375 (9711): 279–280.CrossRefGoogle Scholar
  14. Mansfield, P. (n.d.) Introduction to Healthy Skepticism Inc, http://www.healthyskepticism.org, accessed 16 March 2011.
  15. Jordan, A. (2011) Silence is not always golden. Medical Independent 10 February: 10–4, http://www.medicalindependent.ie/page.aspx?title=silence_is_not_always_golden, accessed 16 March 2011.
  16. Braillon, A. (2011) Challenging special interest groups: Whistleblowers may help. Help them! Psychotherapy Psychosomatics 80 (2): 116–117.CrossRefGoogle Scholar
  17. Braillon, A. and Dubois, G. (2010) Whistleblowing and the abuse of libel law: A view from France. HealthWatch Newsletter, issue 79, p. 3, 7, http://braillon.net/alain/healthwatch_oct10.pdf, accessed 16 March 2011.

Copyright information

© Palgrave Macmillan, a division of Macmillan Publishers Ltd 2011

Authors and Affiliations

  • Alain Braillon
    • 1
  1. 1.GresAmiensFrance

Personalised recommendations